HMCIB SPAC 3 (226340) - Total Assets
Based on the latest financial reports, HMCIB SPAC 3 (226340) holds total assets worth ₩89.61 Billion KRW (≈ $60.73 Million USD) as of September 2024. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 226340 cash flow conversion for how efficiently the company converts equity into cash flow.
HMCIB SPAC 3 - Total Assets Trend (2015–2023)
This chart illustrates how HMCIB SPAC 3's total assets have evolved over time, based on quarterly financial data. See HMCIB SPAC 3 share price for real-time trading data and today's change.
HMCIB SPAC 3 - Asset Composition Analysis
Current Asset Composition (December 2023)
HMCIB SPAC 3's total assets of ₩89.61 Billion consist of 35.1% current assets and 64.9% non-current assets. Explore HMCIB SPAC 3 working capital to net assets to assess how much short-term liquidity the company maintains relative to its equity base.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 9.3% |
| Accounts Receivable | ₩9.75 Billion | 11.2% |
| Inventory | ₩6.31 Billion | 7.2% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩6.73 Billion | 7.7% |
| Goodwill | ₩16.83 Billion | 19.2% |
Asset Composition Trend (2015–2023)
This chart illustrates how HMCIB SPAC 3's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: HMCIB SPAC 3's current assets represent 35.1% of total assets in 2023, a decrease from 100.0% in 2015.
- Cash Position: Cash and equivalents constituted 9.3% of total assets in 2023, up from 0.4% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 26.0% of total assets, an increase from 0.0% in 2015.
- Asset Diversification: The largest asset category is goodwill at 19.2% of total assets.
HMCIB SPAC 3 Competitors by Total Assets
Key competitors of HMCIB SPAC 3 based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Guangdong Marubi Biotechnology Co
SHG:603983
|
China | CN¥4.63 Billion |
|
Hangzhou Haoyue Personal Care Co Ltd
SHG:605009
|
China | CN¥5.22 Billion |
|
Cosmecca Korea Co. Ltd
KQ:241710
|
Korea | ₩734.66 Billion |
|
Qingdao Kingking Applied Chemistry Co Ltd
SHE:002094
|
China | CN¥3.19 Billion |
|
Kolmar Holding
KO:024720
|
Korea | ₩1.31 Trillion |
|
Tonymoly Co Ltd
KO:214420
|
Korea | ₩235.50 Billion |
|
Kuangli Photoelectric Technology Co Ltd
TW:6431
|
Taiwan | NT$1.13 Billion |
|
C&C International Corp.
KQ:352480
|
Korea | ₩311.64 Billion |
HMCIB SPAC 3 - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.71 | 1.23 | 4.70 |
| Quick Ratio | 1.71 | 1.01 | 4.12 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩14.30 Billion | ₩5.75 Billion | ₩22.48 Billion |
HMCIB SPAC 3 - Advanced Valuation Insights
This section examines the relationship between HMCIB SPAC 3's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.10 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 3.4% |
| Total Assets | ₩87.48 Billion |
| Market Capitalization | $181.67 Million USD |
Valuation Analysis
Below Book Valuation: The market values HMCIB SPAC 3's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: HMCIB SPAC 3's assets grew by 3.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for HMCIB SPAC 3 (2015–2023)
The table below shows the annual total assets of HMCIB SPAC 3 from 2015 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | ₩87.48 Billion ≈ $59.29 Million |
+3.41% |
| 2022-12-31 | ₩84.60 Billion ≈ $57.33 Million |
+1.26% |
| 2021-12-31 | ₩83.55 Billion ≈ $56.62 Million |
+53.40% |
| 2020-12-31 | ₩54.46 Billion ≈ $36.91 Million |
+32.62% |
| 2019-12-31 | ₩41.07 Billion ≈ $27.83 Million |
+19.61% |
| 2018-12-31 | ₩34.34 Billion ≈ $23.27 Million |
+151.82% |
| 2017-12-31 | ₩13.64 Billion ≈ $9.24 Million |
+1.10% |
| 2016-12-31 | ₩13.49 Billion ≈ $9.14 Million |
+1.41% |
| 2015-12-31 | ₩13.30 Billion ≈ $9.01 Million |
-- |
About HMCIB SPAC 3
Bonne Co., Ltd. develops and supplies cosmetics in South Korea. The company offers skin care products, including whitening, wrinkle and pimple treatment, stem-cell peptide, and nano peptide products; and sun care products comprising fluids, creams, emulsions, etc. It also provides hair and body care products; makeup products, such as foundation, powder, compact, loose powder, BB cream, eye liner,… Read more